These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37862205)

  • 1. Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases.
    Romano R; Bucci C
    Neural Regen Res; 2024 May; 19(5):1027-1035. PubMed ID: 37862205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense Drugs Make Sense for Neurological Diseases.
    Bennett CF; Kordasiewicz HB; Cleveland DW
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():831-852. PubMed ID: 33035446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.
    Bennett CF; Krainer AR; Cleveland DW
    Annu Rev Neurosci; 2019 Jul; 42():385-406. PubMed ID: 31283897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials.
    Imbimbo BP; Triaca V; Imbimbo C; Nisticò R
    Neural Regen Res; 2023 Aug; 18(8):1679-1683. PubMed ID: 36751779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense therapies for movement disorders.
    Scoles DR; Pulst SM
    Mov Disord; 2019 Aug; 34(8):1112-1119. PubMed ID: 31283857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases.
    Qu Y; Liu Y; Noor AF; Tran J; Li R
    Neural Regen Res; 2019 Jun; 14(6):931-938. PubMed ID: 30761996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROCK inhibition in models of neurodegeneration and its potential for clinical translation.
    Koch JC; Tatenhorst L; Roser AE; Saal KA; Tönges L; Lingor P
    Pharmacol Ther; 2018 Sep; 189():1-21. PubMed ID: 29621594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
    Wang Y; Lv MN; Zhao WJ
    Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases.
    Yu H; Xiong M; Zhang Z
    Front Mol Neurosci; 2023; 16():1209703. PubMed ID: 37781096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cell strategies for rebuilding the human brain.
    Limone F; Klim JR; Mordes DA
    Front Aging Neurosci; 2022; 14():1017299. PubMed ID: 36408113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
    Donde A; Wong PC; Chen LL
    Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
    Gao J; Wang L; Liu J; Xie F; Su B; Wang X
    Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for neurodegenerative disorders: advances, insights and prospects.
    Chen W; Hu Y; Ju D
    Acta Pharm Sin B; 2020 Aug; 10(8):1347-1359. PubMed ID: 32963936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases.
    Onyango IG; Bennett JP; Stokin GB
    Neural Regen Res; 2021 Aug; 16(8):1467-1482. PubMed ID: 33433460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review.
    Wang Q; Xue H; Yue Y; Hao S; Huang SH; Zhang Z
    Front Mol Neurosci; 2022; 15():1014251. PubMed ID: 36267702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.